The peptides your body already makes

Ask most people to name a peptide and you'll get either a blank look or a supplement brand. The more accurate answer is that a few dozen of them are working inside the reader right now, coordinating blood sugar, water balance, digestion, childbirth, and the first hours of any immune response. They are not exotic. They are the ordinary vocabulary of physiological signalling.

The hormones everyone has heard of

Insulin is the standard example. It's produced by the beta cells of the pancreatic islets and released when blood glucose rises after a meal. Structurally it's two chains — 21 residues and 30 — held together by disulfide bridges between cysteine residues, and it starts life as a single longer chain that gets cut and folded into its mature form. Its job is to tell muscle, fat, and liver cells to take glucose out of circulation and store it. Glucagon, from the alpha cells of the same islets, is its counterpart: 29 residues, released when glucose falls, telling the liver to release stored glucose back out. Two peptides, opposite directions, one tightly regulated variable.

Oxytocin and vasopressin are the pair that shows how much a couple of residues can matter. Both are nine-residue peptides. Both are synthesized in the hypothalamus — in the paraventricular and supraoptic nuclei — and transported down axons to the posterior pituitary, where they're stored and released into the bloodstream. They differ at only two positions in the sequence, and they do entirely different things. Oxytocin acts on uterine smooth muscle during labour and on the milk-ejection reflex during nursing. Vasopressin, also called antidiuretic hormone, acts on the kidney to concentrate urine and conserve water. Two positions.

Oxytocin's sequence begins Cys–Tyr–Ile–Gln–Asn — cysteine, tyrosine, isoleucine, glutamine, asparagine — and that opening cysteine forms a disulfide bond with a second cysteine further along, closing part of the chain into a ring. It is the same molecule Vincent du Vigneaud synthesized in 1953, the first polypeptide hormone ever made in a flask. We tell that story in our history explainer.

The immune system's chemistry set

Not every peptide is a messenger. The defensins are a family of small antimicrobial peptides, typically around 18 to 45 residues, produced by neutrophils and by the epithelial cells lining the gut, airways, and skin. They are part of innate immunity — the fast, non-specific response that acts long before antibodies are available.

Their mechanism is largely physical rather than biochemical, which is what makes them interesting. Defensins carry a strong positive charge and have a distinct hydrophobic face. Bacterial membranes are more negatively charged on their outer surface than human cell membranes are, so the peptides are drawn preferentially to microbes, insert into the membrane, and disrupt it enough to kill the cell. Because they attack a structural feature rather than a specific protein target, resistance is harder for a bacterium to evolve than it is against a conventional antibiotic — one reason antimicrobial peptides remain an active research area. Related families appear across essentially all multicellular life; the cathelicidins are another human group, and frogs and insects have their own.

Why short chains, and not something else?

A reasonable question: the body can build molecules of almost any size, so why route so much signalling through chains of ten to forty amino acids? Three properties, mostly.

They're specific. Twenty amino acids arranged in a chain of even modest length give an enormous number of distinct possibilities, each with a different shape and charge distribution. That means a signalling molecule can be designed — over evolutionary time — to fit one receptor and be ignored by everything else. The oxytocin and vasopressin example cuts both ways: sequences that similar can still be discriminated by their respective receptors, most of the time.

They're fast to make and easy to modify. Peptides are built by the same ribosomal machinery that makes every protein, so no dedicated synthetic pathway is required. A single precursor can be cut into several active products, and small chemical modifications — amidating the end of the chain, forming a disulfide bridge, clipping off a few residues — can switch activity on or off without building anything new.

They're easy to get rid of. This may be the most important one. A signal is only useful if it can be turned off, and peptides are cleared quickly by enzymes called peptidases that cut them apart, and by filtration in the kidney. Native GLP-1, the gut hormone released after eating, survives roughly a couple of minutes in circulation before an enzyme cleaves it. In physiology that's a feature: it lets the body send a sharp, time-limited message rather than a signal that lingers. It also happens to be the central obstacle in turning any peptide into a medicine, which is why so much pharmaceutical chemistry has gone into slowing that clearance down.

What this does and doesn't tell you

Understanding that the body makes peptides is genuinely useful context. It explains why the class has been medically interesting for a century, and it deflates the idea that "peptide" names some novel category of substance. It is ordinary biochemistry, described in our foundations piece.

What it does not tell you is anything about whether any particular peptide belongs in any particular person. "Your body makes it" is not a safety argument — your body also makes it in a specific place, at a specific time, in a specific amount, in response to a specific signal, and none of that context transfers. Most peptides discussed outside clinical settings are investigational compounds: not FDA-approved, not dietary supplements, and in most cases without the human safety data that would let anyone make a responsible claim about them either way. The peer-reviewed literature and ClinicalTrials.gov are where the actual evidence lives, and a licensed clinician is who to ask about your own situation. Backbone sells nothing and recommends nothing.